Literature DB >> 6599665

Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension.

M D Blaufox, H G Langford, A Oberman, C M Hawkins, S W Wassertheil-Smoller, G R Cutter.   

Abstract

The possibility exists that dietary modification may increase the number of patients who remain normotensive after drug withdrawal. In an effort to resolve this question, former Hypertension Detection and Follow-up Program Stepped Care participants (n = 496) were randomized into four major groups at the end of the programme (greater than 5 years antihypertensive therapy): controls (continue medication); discontinue medication, no dietary intervention; discontinue medication and weight loss; discontinue medication and reduce sodium. Groups 1, 2 and 4 were further divided into obese (greater than or equal to 120% ideal weight, and non-obese groups). The weight reduction group (greater than or equal to 120% ideal weight) lost 10.1 +/- 11 lbs without changing dietary sodium (n = 87). The sodium restriction group reduced urine sodium excretion from 145 to 97 mEq per day (n = 169). Sixty per cent of the weight loss group were normotensive at 56 weeks compared to 35% withdrawn from medication without dietary intervention. The highest 56 weeks success rates were in the mild non-overweight hypertensives on sodium restriction (78%), and the mild overweight hypertensives on weight reduction (72%). Randomization to either weight loss group or sodium restriction group increased the likelihood of remaining off drugs (adjusted odds ratio of 3.43 for the weight group and 2.17 for the sodium group (P less than 0.05). Age, severe hypertension greater than 5 years previous to entry into Dietary Intervention Study of Hypertension (DISH) or need for several drugs increased the chance of failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6599665

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  9 in total

Review 1.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 2.  Economic factors in the initiation of antihypertensive therapy.

Authors:  I Kawachi
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

Review 3.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

4.  Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort.

Authors:  Mark R Nelson; Chris M Reid; Henry Krum; Tui Muir; Philip Ryan; John J McNeil
Journal:  BMJ       Date:  2002-10-12

Review 5.  Long-term effects of weight-reducing diets in people with hypertension.

Authors:  Thomas Semlitsch; Klaus Jeitler; Andrea Berghold; Karl Horvath; Nicole Posch; Stephanie Poggenburg; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2016-03-02

Review 6.  Antihypertensive withdrawal for the prevention of cognitive decline.

Authors:  Susan Jongstra; Jennifer K Harrison; Terry J Quinn; Edo Richard
Journal:  Cochrane Database Syst Rev       Date:  2016-11-01

7.  Long-term effects of weight-reducing diets in people with hypertension.

Authors:  Thomas Semlitsch; Cornelia Krenn; Klaus Jeitler; Andrea Berghold; Karl Horvath; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2021-02-08

8.  Withdrawal of antihypertensive drugs in older people.

Authors:  Emily Reeve; Vanessa Jordan; Wade Thompson; Mouna Sawan; Adam Todd; Todd M Gammie; Ingrid Hopper; Sarah N Hilmer; Danijela Gnjidic
Journal:  Cochrane Database Syst Rev       Date:  2020-06-10

9.  Comprehensive Approach to Lower Blood Pressure (CALM-BP): a randomized controlled trial of a multifactorial lifestyle intervention.

Authors:  A Ziv; O Vogel; D Keret; S Pintov; E Bodenstein; K Wolkomir; K Doenyas; Y Mirovski; S Efrati
Journal:  J Hum Hypertens       Date:  2013-04-18       Impact factor: 3.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.